Serological biomarkers for management of primary sclerosing cholangitis

doi:10.3748/wjg.v28.i21.2291

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6596)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

496

WORD

110

HTML

4368

Figures (1-2)

431

Sum=5405

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

373

Download

818

Sum=1191

Jun 7, 2022 (publication date) through May 12, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Jun 7, 2022; 28(21): 2291-2301
Published online Jun 7, 2022. doi: 10.3748/wjg.v28.i21.2291

Full Size Figure Download Figure

Figure 2 Biomarkers with potential to predict the clinical course of primary sclerosing cholangitis. The markers have various cellular origins, and some (LPS-binding protein, interleukin-8, and enzymes) have multiple sources that limit their specificity. ALP: Alkaline phosphatase; AST: Aspartate aminotransferase; GP2: Pancreatic glycoprotein 2; IL: Interleukin; LBP: Lipopolysaccharide binding protein; miR: Micro-ribonucleic acid; sMR: Soluble mannose receptor; sVAP: Soluble vascular adhesion protein.

Citation: Tornai D, Ven PL, Lakatos PL, Papp M. Serological biomarkers for management of primary sclerosing cholangitis. World J Gastroenterol 2022; 28(21): 2291-2301
URL: https://www.wjgnet.com/1007-9327/full/v28/i21/2291.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i21.2291